✦ LIBER ✦

Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer

✍ Scribed by Nguewa, Paul A; Calvo, Alfonso; Pullamsetti, Soni Savai; Banat, Gamal Andre; Grimminger, Friedrich; Savai, Rajkumar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second generation tyrosine kinase inhibi

✍ Stasi, Irene; Cappuzzo, Federico 📂 Article 📅 2014 🏛 Springer (Biomed Central Ltd.) ⚖ 320 KB

Erlotinib: an EGF receptor tyrosine kina

✍ Schettino, Clorinda; Bareschino, Maria Anna; Ricci, Vincenzo; Ciardiello, Fortun 📂 Article 📅 2008 🏛 Expert Reviews 🌐 English ⚖ 301 KB

Accuracy of RECIST 1.1 for non-small cel

✍ Sun, Jong-Mu; Ahn, Myung-Ju; Park, Min Jae; Yi, Jun Ho; Kim, Tae Sung; Chung, My 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 126 KB

EGF receptor tyrosine kinase inhibitors

✍ Bartolotti, Marco ;Franceschi, Enrico ;Brandes, Alba Ariela 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 896 KB

18 Chemotherapy or tyrosine kinase inhib

✍ Jyoti, B.; McKay, M.; Wong, H.; Alam, F.; Eswar, C.; Jain, P.; Littler, J.A.H.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB

P44 Non small cell lung cancer xenograft

✍ J. Rolff; J. Merk; S. Lee; R. Soong; M. Becker; A. Sommer; I. Fichtner 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB